These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3615563)

  • 1. [Hydrolysis products of the carcinostatic, Cytostasan (bendamustin)].
    Werner W; Letsch G; Ihn W
    Pharmazie; 1987 Apr; 42(4):272-3. PubMed ID: 3615563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)].
    Werner W; Letsch G; Ihn W; Sohr R; Preiss R
    Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability studies of 14C-Cytostasan solutions and its extraction using dicarbolide of cobalt.
    Scasnár V; Bezek S; Trnovec T; Lisse I; Grupe R
    Pharmazie; 1988 Mar; 43(3):176-8. PubMed ID: 3380859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
    Vogel CL; Denham C; Waalkes TP; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential anticancer agents. VII. Relationship between basicity of precursor unsubstituted amines and hydrolysis rate of corresponding aromatic nitrogen mustards.
    Niculescu-Duvaz I; Botez G; Serban A
    Neoplasma; 1970; 17(2):143-54. PubMed ID: 5425392
    [No Abstract]   [Full Text] [Related]  

  • 6. A method of evaluation of quality of 4-methyl-5-(bis-(beta-chloroethyl)-amino)-uracil.
    Grabowska I; Kaliszan R; Kuciński W
    Pol J Pharmacol Pharm; 1973; 25(6):621-6. PubMed ID: 4792485
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of the intramolecular cyclization of bis(2-chlorethyl)aminoethyl esters of carboxylic acids.
    Natcheva R; Manolov I; Golovinsky EV
    Pharmazie; 1986 Sep; 41(9):642-4. PubMed ID: 3797454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationships between chemical structure and biological activity in azomethines with nitrogen mustard groups on Ehrlich ascites tumor of the white mouse. 2. Azomethine without N-mustard groups as comparative substances and N-mustard azomethine with additional substitutions in the phenyl group].
    Schulze W; Gutsche W; Jungstand W
    Arzneimittelforschung; 1967 May; 17(5):605-7. PubMed ID: 5631589
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard.
    De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G
    Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intramolecular cyclization of nitrogen mustard compounds].
    Schulze W
    Pharmazie; 1975 May; 30(5):265-70. PubMed ID: 1101275
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of the reaction of native and denatured DNA with a chromophore derivative of nitrogen mustard].
    Morozova TM; Gorel' FL; Salganik RI
    Biokhimiia; 1965; 30(1):67-73. PubMed ID: 5870890
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrospray mass spectrometric analysis of new alpha-MSH analogues carrying nitrogen mustard at their amino terminus.
    Van Beeumen J; Devreese B; Ghanem G; Lejeune F; Deknop C; Faignet C; Toch I; Jacquemotte F
    Pept Res; 1994; 7(1):7-12. PubMed ID: 8019062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUMOUR CHEMOTHERAPY. X. NITROGEN MUSTARDS DERIVATIVES OF CHLORAMPHENICOL AND THEIR ANTITUMOUR ACTION.
    JEN YF; CHOU CH; CHOW SW; HSU B; KAO YS
    Sci Sin; 1963 Aug; 12():1135-47. PubMed ID: 14073299
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential errors in kinetic studies of hydrolysis of nitrogen mustards based on chloride-ion determination.
    Chatterji DC
    J Pharm Sci; 1980 Jul; 69(7):859-62. PubMed ID: 7391957
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme activated anti-tumour agents--III. Hydrolysis of conjugates of p-hydroxyaniline mustard in aqueous solution.
    Workman P; Double JA; Wilman DE
    Biochem Pharmacol; 1976 Nov; 25(21):2347-50. PubMed ID: 999722
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of potentially cytoactive peptide mustards.
    Chakrabarti JK; Friedman OM
    Chem Ind; 1965 May; 21():898-9. PubMed ID: 5827496
    [No Abstract]   [Full Text] [Related]  

  • 17. [Potential nitrogen lost transport forms. 2. Bis-(beta-chlorethyl)-carbamoylderivatives of benzimidazolones, benzimidazolthiones and benzimidazolonimides].
    Schulze W; Letsch G
    Pharmazie; 1973 Jun; 28(6):367-71. PubMed ID: 4726393
    [No Abstract]   [Full Text] [Related]  

  • 18. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
    Pütter J; Maral R; Bierling R; Steinhoff D
    Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
    Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
    Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential anticancer agents. 3. Preparation of amino acid derivatives of bis(beta-chloroethyl)-phosphoramidic dichloride].
    Sung WL; Hou SZ; Zhao HP; Yang JH; Ja XX
    Yao Xue Xue Bao; 1966 Feb; 13(2):126-30. PubMed ID: 5952403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.